-
SFDA issues requirements for application and acceptance of administrative licensing for cosmeticsIn order to further standardize the application and acceptance of administrative licensing for cosmetics, the State Food and Drug Administration (SFDA) recently issued requirements for2010/1/5
-
Echo Therapeutics Develops Prelude SkinPrep SystemAs a platform technology for enhanced skin permeation for transdermal drug delivery Echo Therapeutics has provided updates on the development of its needle-free Prelude SkinPrep System for transderma2010/1/4
-
Special Review and Approval Procedure for Drug Registration of the State Food and Drug AdministrationSpecial Review and Approval Procedure for Drug Registration of the State Food and Drug Administration (SFDA Decree No. 21) The Special Review and Approval Procedure for Drug Re2010/1/4
-
SFDA:Provisions for Drug RegistrationSFDA:Provisions for Drug Registration (SFDA Order No. 28)Provisions for Drug Registration Chapter IGeneral Provisions Article 1 The Provisions are formulated for the purposes2010/1/4
-
SFDA:Provisions for Drug Insert Sheets and LabelsSFDA:Provisions for Drug Insert Sheets and Labels (SFDA Decree No.24) The Provisions for Drug Insert Sheets and Labels, adopted at the executive meeting of the State Food and D2009/12/31
-
SFDA:Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim)SFDA:Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim) (SFDA Decree No. 25)The Provisions for Import and Export of Anabolic Agents and Peptide2009/12/31
-
SFDA issues Good Manufacturing Practice for Medical Devices (interim) and Requirements for Medical Device GMP Inspection (interim)In order to intensify supervision on medical device manufacturing, standardize quality management systems for medical device manufacturing, strengthen the management of medical device GMP insp2009/12/31
-
PTC Therapeutics Closes $50-Million FinancingPTC Therapeutics, Inc. recently announced the completion of a $50-million financing. The round was led by The Column Group (a new investor) and existing investor Delphi Ventures. The co-lead i2009/12/30
-
Activaero’s AKITA JET Receives FDA 510(k) ClearanceActivaero, a world leader in the design of controlled breathing drug delivery technologies that maximize the efficiency and precision of inhaled drugs, recently announced that the US FDA has i2009/12/30
-
Athersys Inks Deal With Pfizer on Stem-Cell TherapyAthersys, Inc. recently announced it has entered into an agreement with Pfizer Inc. to develop and commercialize MultiStem for the treatment of Inflammatory BowlDisease (IBD). MultiStem is an2009/12/30